Cookie Consent by FreePrivacyPolicy.com
Datalog Logo
Free data on 57M+ companies
Home > England & Wales Companies > REDX PHARMA LIMITED
Company Information for

REDX PHARMA LIMITED

BLOCK 33 MERESIDE, ALDERLEY PARK, MACCLESFIELD, SK10 4TG,
Company Registration Number
07368089
Private Limited Company
Active

Company Overview

About Redx Pharma Ltd
REDX PHARMA LIMITED was founded on 2010-09-07 and has its registered office in Macclesfield. The organisation's status is listed as "Active". Redx Pharma Limited is a Private Limited Company registered in ENGLAND with Companies House and the accounts submission requirement is categorised as GROUP
  • Group companies must submit full accounts if any company is a PLC (Public Limited Company)
  • Financial services firms: authorised insurance company, a banking company, an e-money issuer, a MiFID investment firm or a UCITS management company must submit full accounts even if they qualify as small
  • The combined turnover of the group must be < £6.5M, balance sheet <£3.26M and employ less than 50 people to not submit full accounts
Key Data
Company Name
REDX PHARMA LIMITED
 
Legal Registered Office
BLOCK 33 MERESIDE
ALDERLEY PARK
MACCLESFIELD
SK10 4TG
Other companies in M2
 
Filing Information
Company Number 07368089
Company ID Number 07368089
Date formed 2010-09-07
Country ENGLAND
Origin Country United Kingdom
Type Private Limited Company
CompanyStatus Active
Lastest accounts 30/09/2023
Account next due 30/06/2025
Latest return 07/09/2015
Return next due 05/10/2016
Type of accounts GROUP
VAT Number /Sales tax ID GB172108923  
Last Datalog update: 2024-10-05 08:12:10
Primary Source:Companies House
There are multiple companies registered at this address, the registered address may be the accountant's offices for REDX PHARMA LIMITED
Is this data useful to you?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.
Companies with same name REDX PHARMA LIMITED
The following companies were found which have the same name as REDX PHARMA LIMITED. These may be the same company in different jurisdictions
  Registered addressLast known statusFormation date
REDX PHARMA PLC Unknown

Company Officers of REDX PHARMA LIMITED

Current Directors
Officer Role Date Appointed
ANDREW WILLIAM BOOTH
Company Secretary 2017-05-16
LISA MARY WHEWELL ANSON
Director 2018-06-01
DOMINIC NICHOLAS JACKSON
Director 2017-11-03
BERNHARD JURGEN KIRSCHBAUM
Director 2016-01-01
PETER ERIC PRESLAND
Director 2017-11-03
IAIN GLADSTONE ROSS
Director 2017-05-01
Previous Officers
Officer Role Date Appointed Date Resigned
NORMAN MOLYNEUX
Director 2010-09-07 2017-11-03
NEIL DAVID MURRAY
Director 2010-09-20 2017-11-03
DAVID MUIR LAWRENCE
Director 2016-05-06 2017-08-14
SIMON WILLIAM THORN
Company Secretary 2010-09-20 2017-05-16
FRANK MURDOCH ARMSTRONG
Director 2014-09-01 2017-04-20
PETER MCPARTLAND
Director 2010-10-18 2017-04-20
PETER JACKSON
Director 2010-09-20 2017-03-31
PHILIP JOHN TOTTEY
Director 2015-03-25 2016-09-30
DEREK LINDSAY
Director 2010-09-20 2016-05-06
PHILIP LEON GOULD
Director 2010-09-20 2014-05-31
DENNIS WILLIAM PATRICK HALLAHANE
Director 2011-11-15 2014-05-21
DOUGLAS COLIN WALTER STELLMAN
Director 2010-09-20 2011-04-20

Related Directorships

Officer Related Company Role Date Appointed Role StatusIncorporation dateCompany Status
DOMINIC NICHOLAS JACKSON REDX ONCOLOGY LTD Director 2018-02-07 CURRENT 2011-12-05 Active
DOMINIC NICHOLAS JACKSON REDX ANTI-INFECTIVES LTD Director 2018-02-07 CURRENT 2012-07-09 Liquidation
DOMINIC NICHOLAS JACKSON REDX IMMUNOLOGY LIMITED Director 2018-02-07 CURRENT 2014-04-16 Active
DOMINIC NICHOLAS JACKSON GIELEN PARTNERS LIMITED Director 2013-10-24 CURRENT 2013-10-24 Liquidation
PETER ERIC PRESLAND ICONIC LABS PLC Director 2017-12-21 CURRENT 2016-05-24 Active
PETER ERIC PRESLAND BEAUTIFUL INFORMATION LIMITED Director 2015-10-01 CURRENT 2013-11-22 Active
PETER ERIC PRESLAND MAINVALLEY LIMITED Director 1994-09-27 CURRENT 1984-10-18 Active
PETER ERIC PRESLAND ROOKHILL LIMITED Director 1991-11-15 CURRENT 1979-09-28 Active
PETER ERIC PRESLAND CLAUSEGATE LIMITED Director 1991-11-15 CURRENT 1980-11-25 Active
IAIN GLADSTONE ROSS REDX ONCOLOGY LTD Director 2017-11-03 CURRENT 2011-12-05 Active
IAIN GLADSTONE ROSS REDX ANTI-INFECTIVES LTD Director 2017-11-03 CURRENT 2012-07-09 Liquidation
IAIN GLADSTONE ROSS REDX IMMUNOLOGY LIMITED Director 2017-11-03 CURRENT 2014-04-16 Active
IAIN GLADSTONE ROSS REDX MRSA LIMITED Director 2017-11-03 CURRENT 2014-09-04 Liquidation

More director information

Corporation Filing History
Companies House Filing History
This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

DateDocument TypeDocument Description
2024-09-19CONFIRMATION STATEMENT MADE ON 07/09/24, WITH UPDATES
2024-08-14Resolutions passed:<ul><li>Resolution on securities</ul>
2024-08-14Resolutions passed:<ul><li>Resolution on securities<li>Resolution passed adopt articles</ul>
2024-08-12Memorandum articles filed
2024-08-0802/08/24 STATEMENT OF CAPITAL GBP 4212439.81
2024-05-09Resolutions passed:<ul><li>Resolution re-registration</ul>
2024-05-09Re-registration of memorandum and articles of association
2024-05-09Certificate of re-registration from Public Limited Company to Private
2024-05-09Re-registration from a public company to a private limited company
2024-03-29GROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/23
2023-12-05Resolutions passed:<ul><li>Resolution passed removal of pre-emption</ul>
2023-12-05Resolutions passed:<ul><li>Resolution passed removal of pre-emption<li>Resolution on securities</ul>
2023-10-02APPOINTMENT TERMINATED, DIRECTOR SARAH LUCINDA GORDON WILD
2023-09-20CONFIRMATION STATEMENT MADE ON 07/09/23, WITH NO UPDATES
2023-09-07DIRECTOR APPOINTED DR JOSEPH ANDERSON
2023-09-01APPOINTMENT TERMINATED, DIRECTOR THOMAS HENRY BURT
2023-03-22GROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/22
2023-03-22GROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/22
2023-03-21Resolutions passed:<ul><li>Resolution on securities</ul>
2023-03-21Resolutions passed:<ul><li>Resolution on securities</ul>
2023-03-21Resolutions passed:<ul><li>Resolution on securities<li>Resolution passed removal of pre-emption</ul>
2023-03-21Resolutions passed:<ul><li>Resolution on securities<li>Resolution passed removal of pre-emption</ul>
2023-03-21Resolutions passed:<ul><li>Resolution on securities<li>Resolution passed removal of pre-emption<li>Resolution Re-appointment of auditor, re-election of director 14/03/2023</ul>
2023-03-21Resolutions passed:<ul><li>Resolution on securities<li>Resolution passed removal of pre-emption<li>Resolution Re-appointment of auditor, re-election of director 14/03/2023</ul>
2022-09-20CS01CONFIRMATION STATEMENT MADE ON 07/09/22, WITH NO UPDATES
2022-09-01Appointment of Claire Penelope Solk as company secretary on 2022-09-01
2022-09-01Termination of appointment of Andrew William Booth on 2022-09-01
2022-09-01TM02Termination of appointment of Andrew William Booth on 2022-09-01
2022-09-01AP03Appointment of Claire Penelope Solk as company secretary on 2022-09-01
2022-07-28SH0127/07/22 STATEMENT OF CAPITAL GBP 3349114.58
2022-06-14RES11Resolutions passed:
  • Resolution of removal of pre-emption rights
  • Resolutions
  • Resolution of allotment of securities
2022-06-08SH0107/06/22 STATEMENT OF CAPITAL GBP 3333531.61
2022-03-17AAGROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/21
2022-03-15RES10Resolutions passed:
  • Resolution of allotment of securities
  • Resolution of removal of pre-emption rights
  • 08/03/2022
2022-01-27DIRECTOR APPOINTED DR ROBERT ANDREW DONALD SCOTT
2022-01-27AP01DIRECTOR APPOINTED DR ROBERT ANDREW DONALD SCOTT
2021-12-01AP01DIRECTOR APPOINTED DR JANE VERONICA GRIFFITHS
2021-10-15SH0127/09/21 STATEMENT OF CAPITAL GBP 2752822.05
2021-09-16CS01CONFIRMATION STATEMENT MADE ON 07/09/21, WITH UPDATES
2021-06-09AUDAUDITOR'S RESIGNATION
2021-06-03TM01APPOINTMENT TERMINATED, DIRECTOR IAIN GLADSTONE ROSS
2021-05-19AP01DIRECTOR APPOINTED MS NATALIE BERNER
2021-03-25RES10Resolutions passed:
  • Resolution of allotment of securities
  • Resolution of removal of pre-emption rights
  • Company business 02/03/2021
2021-03-19AAGROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/20
2021-03-03TM01APPOINTMENT TERMINATED, DIRECTOR JAMES ROBERT MEAD
2021-01-19SH0122/12/20 STATEMENT OF CAPITAL GBP 2738872.13
2021-01-19RES11Resolutions passed:
  • Resolution of removal of pre-emption rights
  • Resolution of allotment of securities
2020-09-18CS01CONFIRMATION STATEMENT MADE ON 07/09/20, WITH NO UPDATES
2020-08-10AP01DIRECTOR APPOINTED MR THOMAS HENRY BURT
2020-08-10MR04 STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE CODE 073680890003
2020-08-07MR01REGISTRATION OF A CHARGE / CHARGE CODE 073680890004
2020-08-06RES11Resolutions passed:
  • Resolution of removal of pre-emption rights
  • Resolutions
  • Resolution of allotment of securities
2020-08-06SH0121/07/20 STATEMENT OF CAPITAL GBP 1952474.13
2020-07-07AP01DIRECTOR APPOINTED MRS SARAH LUCINDA GORDON WILD
2020-05-01TENDLondon Stock Exchange corporate action. Tender/Acquisition/Takeover/Purchase Offer of ORD GBP0.01 for COAF: UK600129763Y2020 ASIN: GB00BSNB6S51
2020-04-29RES11Resolutions passed:
  • Resolution of removal of pre-emption rights
  • Resolutions
  • Resolution of allotment of securities
2020-04-21PSC01NOTIFICATION OF A PERSON WITH SIGNIFICANT CONTROL JEREMY CHARLES GREEN
2020-04-20PSC07CESSATION OF MOULTON GOODIES LTD AS A PERSON OF SIGNIFICANT CONTROL
2020-04-09TENDLondon Stock Exchange corporate action. Tender/Acquisition/Takeover/Purchase Offer of ORD GBP0.01 for COAF: UK600129763Y2020 ASIN: GB00BSNB6S51
2020-04-03MR01REGISTRATION OF A CHARGE / CHARGE CODE 073680890003
2020-03-31AAGROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/19
2020-03-10SH0128/02/20 STATEMENT OF CAPITAL GBP 1900087.03
2020-03-05PSC02Notification of Moulton Goodies Ltd as a person with significant control on 2020-01-21
2020-03-05PSC09Withdrawal of a person with significant control statement on 2020-03-05
2020-01-28SH0122/01/20 STATEMENT OF CAPITAL GBP 1785087.03
2020-01-28RES11Resolutions passed:
  • Resolution of removal of pre-emption rights
  • Resolutions
  • Resolution of allotment of securities
2020-01-24MR04 STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE CODE 073680890002
2019-10-10CS01CONFIRMATION STATEMENT MADE ON 07/09/19, WITH NO UPDATES
2019-06-12MR01REGISTRATION OF A CHARGE / CHARGE CODE 073680890002
2019-05-03MR04 STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE CODE 073680890001
2019-03-21AAGROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/18
2019-02-07TM01APPOINTMENT TERMINATED, DIRECTOR DOMINIC NICHOLAS JACKSON
2019-02-01AP01DIRECTOR APPOINTED JAMES ROBERT MEAD
2018-09-12CS01CONFIRMATION STATEMENT MADE ON 07/09/18, WITH UPDATES
2018-06-16AP01DIRECTOR APPOINTED LISA MARY WHEWELL ANSON
2018-03-20AAGROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/17
2018-03-12PSC08Notification of a person with significant control statement
2018-03-12PSC09Withdrawal of a person with significant control statement on 2018-03-12
2018-01-08CS01CONFIRMATION STATEMENT MADE ON 07/09/17, WITH UPDATES
2017-11-10AM10NOTICE OF ADMINISTRATOR'S PROGRESS REPORT:LIQ. CASE NO.1
2017-11-10AM21NOTICE OF END OF ADMINISTRATION:LIQ. CASE NO.1
2017-11-10AM10NOTICE OF ADMINISTRATOR'S PROGRESS REPORT:LIQ. CASE NO.1
2017-11-10AM21NOTICE OF END OF ADMINISTRATION:LIQ. CASE NO.1
2017-11-07AP03SECRETARY APPOINTED MR ANDREW WILLIAM BOOTH
2017-11-07AP03SECRETARY APPOINTED MR ANDREW WILLIAM BOOTH
2017-11-06AP01DIRECTOR APPOINTED MR IAIN GLADSTONE ROSS
2017-11-06AP01DIRECTOR APPOINTED MR DOMINIC NICHOLAS JACKSON
2017-11-06AP01DIRECTOR APPOINTED MR PETER ERIC PRESLAND
2017-11-06TM01APPOINTMENT TERMINATED, DIRECTOR NORMAN MOLYNEUX
2017-11-06TM01APPOINTMENT TERMINATED, DIRECTOR NEIL MURRAY
2017-11-06TM02Termination of appointment of Simon William Thorn on 2017-05-16
2017-11-06AD01REGISTERED OFFICE CHANGED ON 06/11/17 FROM 2nd Floor 110 Cannon Street London EC4N 6EU
2017-09-11AM06Notice of deemed approval of proposals
2017-08-24TM01APPOINTMENT TERMINATED, DIRECTOR DAVID MUIR LAWRENCE
2017-08-22AM03Statement of administrator's proposal
2017-07-26AM12NOTICE OF ORDER LIMITING DISCLOSURE OF STATEMENT OF AFFAIRS OR PROPOSALS IN ADMINISTRATION/O/C DISCLOSE:LIQ. CASE NO.1
2017-07-25AM04NOTICE OF EXTENSION OF TIME TO DELIVER ADMINISTRATOR'S PROPOSALS:LIQ. CASE NO.1
2017-07-25AM05NOTICE OF EXTENSION OF TIME TO SEEK APPROVAL OF ADMINISTRATOR'S PROPOSALS:LIQ. CASE NO.1
2017-06-13AD01REGISTERED OFFICE CHANGED ON 13/06/2017 FROM FLOOR 9, LOWRY HOUSE 17 MARBLE STREET MANCHESTER GREATER MANCHESTER M2 3AW
2017-06-07AM01NOTICE OF ADMINISTRATOR'S APPOINTMENT:LIQ. CASE NO.1:IP NO.00014372,00009644
2017-05-03RES12VARYING SHARE RIGHTS AND NAMES
2017-05-03RES10AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES
2017-04-25TM01APPOINTMENT TERMINATED, DIRECTOR PETER MCPARTLAND
2017-04-25TM01APPOINTMENT TERMINATED, DIRECTOR FRANK ARMSTRONG
2017-04-13TM01APPOINTMENT TERMINATED, DIRECTOR PETER JACKSON
2017-04-06AAGROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/16
2017-03-08LATEST SOC08/03/17 STATEMENT OF CAPITAL;GBP 1264779.14
2017-03-08SH0101/03/17 STATEMENT OF CAPITAL GBP 1264779.14
2017-03-08RES10AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES
2017-02-16SH0115/02/17 STATEMENT OF CAPITAL GBP 996979.56
2016-10-05LATEST SOC05/10/16 STATEMENT OF CAPITAL;GBP 935526.38
2016-10-05CS01CONFIRMATION STATEMENT MADE ON 07/09/16, WITH UPDATES
2016-10-04TM01APPOINTMENT TERMINATED, DIRECTOR PHILIP TOTTEY
2016-05-23SH0115/04/16 STATEMENT OF CAPITAL GBP 935526.38
2016-05-18RES11DISAPPLICATION OF PRE-EMPTION RIGHTS
2016-05-18RES10AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES
2016-05-16AP01DIRECTOR APPOINTED MR DAVID MUIR LAWRENCE
2016-05-13TM01APPOINTMENT TERMINATED, DIRECTOR DEREK LINDSAY
2016-03-21AP01DIRECTOR APPOINTED DR BERNHARD JURGEN KIRSCHBAUM
2016-03-15RES11DISAPPLICATION OF PRE-EMPTION RIGHTS
2016-03-15RES10AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES
2016-03-07AAGROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/15
2015-09-24LATEST SOC24/09/15 STATEMENT OF CAPITAL;GBP 649812.09
2015-09-24AR0107/09/15 FULL LIST
2015-09-22RES13CHANGE OF NAME AND THE RE-REGISTRATION AS A PUBLIC COMPANY 18/03/2015
2015-09-22RES01ADOPT ARTICLES 18/03/2015
2015-06-22LATEST SOC22/06/15 STATEMENT OF CAPITAL;GBP 649812.09
2015-06-22SH0127/03/15 STATEMENT OF CAPITAL GBP 649812.09
2015-06-18AUDAUDITOR'S RESIGNATION
2015-05-28AD03REGISTER(S) MOVED TO SAIL ADDRESS 114-REG MEM
2015-05-28AD02SAIL ADDRESS CREATED
2015-04-16SH0117/03/15 STATEMENT OF CAPITAL GBP 473341.50
2015-04-16SH0113/03/15 STATEMENT OF CAPITAL GBP 6981.27
2015-04-16RES13COMPANY BUSINESS 16/03/2015
2015-04-16RES01ALTER ARTICLES 16/03/2015
2015-04-02AP01DIRECTOR APPOINTED MR PHILIP JOHN TOTTEY
2015-03-18MARREREGISTRATION MEMORANDUM AND ARTICLES
2015-03-18RES02REREG PRI TO PLC; RES02 PASS DATE:18/03/2015
2015-03-18AUDSAUDITORS' STATEMENT
2015-03-18AUDRAUDITORS' REPORT
2015-03-18RR01APPLICATION BY A PRIVATE COMPANY FOR RE-REGISTRATION AS A PUBLIC COMPANY
2015-03-18BSBALANCE SHEET
2015-03-18CERT5CERTIFICATE OF REREGISTRATION FROM PRIVATE TO PLC
2015-03-17SH20STATEMENT BY DIRECTORS
2015-03-17CAP-SSSOLVENCY STATEMENT DATED 13/03/15
2015-03-17SH1917/03/15 STATEMENT OF CAPITAL GBP 6311.22
2015-03-17RES06REDUCE ISSUED CAPITAL 16/03/2015
2015-02-10RP04SECOND FILING WITH MUD 07/09/14 FOR FORM AR01
2015-02-10RP04SECOND FILING WITH MUD 07/09/13 FOR FORM AR01
2015-02-10RP04SECOND FILING WITH MUD 07/09/12 FOR FORM AR01
2015-02-10RP04SECOND FILING WITH MUD 07/09/11 FOR FORM AR01
2015-02-10ANNOTATIONClarification
2015-02-03SH20STATEMENT BY DIRECTORS
2015-02-03SH1903/02/15 STATEMENT OF CAPITAL GBP 6776.11
2015-02-03CAP-SSSOLVENCY STATEMENT DATED 02/02/15
2015-02-03RES13REDUCTION OF SHARE PREMIUM ACCOUNT 30/01/2015
2015-02-02AAGROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/14
2014-11-24ANNOTATIONClarification
2014-11-24RP04SECOND FILING FOR FORM SH01
2014-11-24RP04SECOND FILING FOR FORM SH01
2014-11-24RP04SECOND FILING FOR FORM SH01
2014-11-24RP04SECOND FILING FOR FORM SH01
2014-11-24RP04SECOND FILING FOR FORM SH01
2014-11-24RP04SECOND FILING FOR FORM SH01
2014-11-21ANNOTATIONClarification
2014-11-21RP04SECOND FILING FOR FORM SH01
2014-11-21RP04SECOND FILING FOR FORM SH01
2014-11-21RP04SECOND FILING FOR FORM SH01
2014-11-21RP04SECOND FILING FOR FORM SH01
2014-11-21RP04SECOND FILING FOR FORM SH01
2014-11-21RP04SECOND FILING FOR FORM SH01
2014-11-21RP04SECOND FILING FOR FORM SH01
2014-11-21RP04SECOND FILING FOR FORM SH01
2014-11-21RP04SECOND FILING FOR FORM SH01
2014-11-10SH0130/09/14 STATEMENT OF CAPITAL GBP 6776.11
2014-10-02RES13COMPANY BUSINESS 15/09/2014
2014-10-02RES10AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES
2014-09-30AR0107/09/14 FULL LIST
2014-09-30AR0107/09/14 FULL LIST
2014-09-15RP04SECOND FILING WITH MUD 07/09/13 FOR FORM AR01
2014-09-15ANNOTATIONClarification
2014-09-10AP01DIRECTOR APPOINTED MR FRANK MURDOCH ARMSTRONG
2014-08-30ANNOTATIONClarification
2014-08-30RP04SECOND FILING FOR FORM SH01
2014-08-30RP04SECOND FILING FOR FORM SH01
2014-08-30RP04SECOND FILING FOR FORM SH01
2014-08-30RP04SECOND FILING FOR FORM SH01
2014-08-30RP04SECOND FILING FOR FORM SH01
2014-08-30RP04SECOND FILING FOR FORM SH01
2014-07-10MR01REGISTRATION OF A CHARGE / CHARGE CODE 073680890001
2014-06-04TM01APPOINTMENT TERMINATED, DIRECTOR PHILIP GOULD
2014-06-04TM01APPOINTMENT TERMINATED, DIRECTOR DENNIS HALLAHANE
2014-04-29AAACCOUNTS FOR 'SMALL' CO. MADE UP TO 30/09/13
2013-10-10AR0107/09/13 FULL LIST
2013-06-27AAACCOUNTS FOR 'SMALL' CO. MADE UP TO 30/09/12
2013-01-31MEM/ARTSARTICLES OF ASSOCIATION
2012-09-12AR0107/09/12 FULL LIST
2012-01-18AAACCOUNTS FOR 'SMALL' CO. MADE UP TO 30/09/11
2011-12-21AP01DIRECTOR APPOINTED MR DENNIS WILLIAM PATRICK HALLAHANE
2011-10-06AR0107/09/11 FULL LIST
2011-06-24TM01APPOINTMENT TERMINATED, DIRECTOR DOUGLAS STELLMAN
2010-10-27AP01DIRECTOR APPOINTED PETER MCPARTLAND
2010-10-07SH02SUB-DIVISION 20/09/10
2010-10-07RES12VARYING SHARE RIGHTS AND NAMES
2010-10-07RES01ADOPT ARTICLES 20/09/2010
2010-10-07AP03SECRETARY APPOINTED SIMON WILLIAM THORN
2010-10-07AP01DIRECTOR APPOINTED DR NEIL DAVID MURRAY
2010-10-07AP01DIRECTOR APPOINTED DEREK LINDSAY
2010-10-07AP01DIRECTOR APPOINTED PETER JACKSON
2010-10-07AP01DIRECTOR APPOINTED DR PHILIP LEON GOULD
2010-10-07AP01DIRECTOR APPOINTED DOUGLAS COLIN WALTER STELLMAN
2010-09-07MODEL ARTICLESMODEL ARTICLES ADOPTED: PRIVATE LIMITED BY SHARES (AMENDED PROVISIONS)
2010-09-07NEWINCCERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION
Industry Information
SIC/NAIC Codes
72 - Scientific research and development
721 - Research and experimental development on natural sciences and engineering
72110 - Research and experimental development on biotechnology




Licences & Regulatory approval
We could not find any licences issued to REDX PHARMA LIMITED or authorisation from an industry specific regulator to operate. These may not be required.
Share this page on Facebook
Risks
Legal Notices
Other Corp2017-11-08
Notice of 2017-08-25
Appointmen2017-05-31
Fines / Sanctions
No fines or sanctions have been issued against REDX PHARMA LIMITED
Liabilities
Mortgages / Charges
Total # Mortgages/Charges 4
Mortgages/Charges outstanding 1
Mortgages Partially Satisifed 0
Mortgages Satisfied/Paid 3
Details of Mortgagee Charges
Charge Type Date of Charge Charge Status Mortgagee
2014-07-10 Outstanding LIVERPOOL CITY COUNCIL
Intangible Assets
Patents

Intellectual Property Patents Registered by REDX PHARMA LIMITED

REDX PHARMA LIMITED has registered 2 patents

GB2498080 , GB2496972 ,

Domain Names
We do not have the domain name information for REDX PHARMA LIMITED
Trademarks

Trademark applications by REDX PHARMA LIMITED

REDX PHARMA LIMITED is the Original Applicant for the trademark REDOX SWITCH ™ (85490857) through the USPTO on the 2011-12-08
House mark for pharmaceutical preparations
Income
Government Income
We have not found government income sources for REDX PHARMA LIMITED. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as REDX PHARMA LIMITED are:

Outgoings
Business Rates/Property Tax
No properties were found where REDX PHARMA LIMITED is liable for the business rates / property tax. This could be for a number of reasons.
  • The council hasnt published the data
  • We havent found or been able to process the councils data
  • The company is part of a group of companies and another company in the group is liable for business rates
  • The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
  • Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.
Import/Export of Goods
Goods imported/exported by REDX PHARMA LIMITED
OriginDestinationDateImport CodeImported Goods classification description
2018-12-0029339980Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2018-12-0029339980Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2018-11-0038220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2018-11-0038220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2016-10-0029189990Carboxylic acids with additional oxygen function, their anhydrides, halides, peroxides and peroxyacids and their halogenated, sulphonated, nitrated or nitrosated derivatives (excl. only with alcohol, phenol, aldehyde or ketone function, and 2,6-dimethoxybenzoic acid, dicamba [ISO], sodium phenoxyacetate, and 2,4,5-T [ISO] [2,4,5-trichlorophenoxyacetic acid] and its salts and esters)
2016-10-0029339980Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2016-10-0038210000Prepared culture media for the development or maintenance of micro-organisms "incl. viruses and the like" or of plant, human or animal cells
2016-09-0035079090Enzymes and prepared enzymes, n.e.s. (excl. rennet and concentrates thereof, lipoprotein lipase and Aspergillus alkaline protease)
2016-08-0029341000Heterocyclic compounds containing an unfused thiazole ring, whether or not hydrogenated, in the structure
2016-08-0035079090Enzymes and prepared enzymes, n.e.s. (excl. rennet and concentrates thereof, lipoprotein lipase and Aspergillus alkaline protease)
2016-07-0030012010Extracts of glands or other organs or of their secretions, of human origin, for organo-therapeutic uses
2016-06-0038220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2016-04-0029350090Sulphonamides (excl. 3-{1-[7-"hexadecylsulphonylamino"-1H-indole-3-yl]-3-oxo-1H, 3H-naphtho[1,8-cd]pyran-1-yl}-N,N-dimethyl-1H-indole-7-sulphonamide and metosulam "ISO")
2016-03-0038220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2016-02-0035079090Enzymes and prepared enzymes, n.e.s. (excl. rennet and concentrates thereof, lipoprotein lipase and Aspergillus alkaline protease)
2016-01-0029420000Separate chemically defined organic compounds, n.e.s.
2016-01-0038220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-12-0029420000Separate chemically defined organic compounds, n.e.s.
2015-12-0038220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-09-0035079090Enzymes and prepared enzymes, n.e.s. (excl. rennet and concentrates thereof, lipoprotein lipase and Aspergillus alkaline protease)
2015-08-0027122090Paraffin wax containing < 0,75% by weight of oil (excl. synthetic paraffin wax of a molecular weight of >= 460 but <= 1.560)
2015-08-0030029030Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2015-08-0038220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-08-0090189084Instruments and appliances used in medical, surgical or veterinary sciences, n.e.s.
2015-06-0130021098Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2015-06-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-06-0030021098Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2015-06-0038220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-05-0130012090Extracts of glands or other organs or of their secretions, of animals, for organo-therapeutic uses
2015-05-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-05-0030012090Extracts of glands or other organs or of their secretions, of animals, for organo-therapeutic uses
2015-05-0038220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-04-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-04-0038220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-03-0129420000Separate chemically defined organic compounds, n.e.s.
2015-01-0190189084Instruments and appliances used in medical, surgical or veterinary sciences, n.e.s.
2014-12-0190189084Instruments and appliances used in medical, surgical or veterinary sciences, n.e.s.
2014-07-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2014-04-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2014-02-0130012010Extracts of glands or other organs or of their secretions, of human origin, for organo-therapeutic uses
2013-12-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2013-06-0129339980Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2013-05-0129339980Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2013-01-0129173995Aromatic polycarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their halogenated, sulphonated, nitrated or nitrosated derivatives (excl. esters of orthophthalic acid, phthalic anhydride, terephthalic acid and its salts, dimethyl terephthalate, ester or anhydride of tetrabromophthalic acid, benzene-1,2,4-tricarboxylic acid, isophthaloyl dichloride containing by weight <= 0,8% of terephthaloyl dichloride, naphthalene-1,4,5,8-tetracarboxylic acid, tetrachlorophthalic anhydride
2013-01-0129319090Separate chemically defined organo-inorganic compounds (excl. organo-sulphur compounds, tributyltin compounds, tetramethyl lead, tetraethyl lead, dimethyl methylphosphonate, methylphosphonoyl difluoride "methylphosphonic difluoride", methylphosphonoyl dichloride "methylphosphonic dichloride" and those of mercury and (5-Ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphinan-5-yl)methyl methyl methylphosphonate; bis[(5-ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphinan-5-yl)methyl] methylphosphonate; 2,4,6-tripro
2012-10-0129189990Carboxylic acids with additional oxygen function, their anhydrides, halides, peroxides and peroxyacids and their halogenated, sulphonated, nitrated or nitrosated derivatives (excl. only with alcohol, phenol, aldehyde or ketone function, and 2,6-dimethoxybenzoic acid, dicamba [ISO], sodium phenoxyacetate, and 2,4,5-T [ISO] [2,4,5-trichlorophenoxyacetic acid] and its salts and esters)
2012-09-0129173920Ester or anhydride of tetrabromophthalic acid; benzene-1,2,4-tricarboxylic acid; isophthaloyl dichloride, containing by weight 0,8 % or less of terephthaloyl dichloride; naphthalene-1,4,5,8-tetracarboxylic acid; tetrachlorophthalic anhydride; sodium 3,5-bis(methoxycarbonyl)benzenesulphonate
2012-08-0129420000Separate chemically defined organic compounds, n.e.s.
2012-05-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)

For goods imported into the United Kingdom, only imports originating from outside the EU are shown

Legal Notices/Action
Initiating party Event TypeOther Corp
Defending partyREDX PHARMA PLCEvent Date2017-11-08
 
Initiating party Event TypeAppointment of Administrators
Defending partyREDX PHARMA PLCEvent Date2017-05-24
In the High Court of Justice Liverpool District Registry Names and Address of Administrators: Jason Daniel Baker (IP No. 9644 ) and Miles Needham (IP No. 14372 ) both of FRP Advisory LLP , 2nd Floor, 110 Cannon Street, London, EC4N 6EU : Further details contact: The Joint Administrators, Email: cp.london@frpadvisory.com or Tel: 020 3005 4000 . Alternative contact: Email: Michael.Quinn@frpadvisory.com Ag IF21595
 
Initiating party Event TypeNotice of Intended Dividends
Defending partyREDX PHARMA PLCEvent Date2017-05-24
In the High Court of Justice Liverpool District Registry Notice is hereby given that I Miles Needham, the Joint Administrator of the above named Company, appointed on 24 May 2017, intend to declare and distribute a first and final dividend within the period of two months from the last date of proving mentioned below. All creditors of the Company are required, on or before 19 September 2017, which is the last date for proving, to prove their debt by sending to me a written statement of the amount they claim to be due from the Company and, if so requested, to provide such further details or produce such documentary or other evidence as may appear to the Joint Administrator to be necessary. A distribution may be made without regard to the claim of any person in respect of a debt not proved. A creditor who has not proved his debt before the last date for proving mentioned above is not entitled to disturb, by reason that he has not participated in the dividend, the distribution of that dividend or any other dividend declared before his debt is proved. Date of Appointment: 24 May 2017 Office Holder Details: Jason Daniel Baker (IP No. 9644 ) of FRP Advisory LLP , 2nd Floor, 110 Cannon Street, London, EC4N 6EU and Miles Needham (IP No. 14372 ) of FRP Advisory LLP , 4 Beaconsfield Road, St Albans, Hertfordshire, AL1 3RD Further details contact: The Joint Administrators, E-mail: cp.london@frpadvisory.com . Alternative contact: Matthew Kesek. Ag LF51573
 
Government Grants / Awards
Technology Strategy Board Awards
The Technology Strategy Board has not awarded REDX PHARMA LIMITED any grants or awards. Grants from the TSB are an indicator that the company is investing in new technologies or IPR
European Union CORDIS Awards
The European Union has not awarded REDX PHARMA LIMITED any grants or awards.
Ownership
    We could not find any group structure information
    Is this data useful to you?
    If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
    Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.
    Need more information?
    We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.